サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：胸腔ドレナージデバイスの世界市場 - 2023年～2030年
市場調査レポート
商品コード
1374796

胸腔ドレナージデバイスの世界市場 - 2023年～2030年

Global Thoracic Drainage Devices Market -2023-2030

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
胸腔ドレナージデバイスの世界市場 - 2023年～2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

より低侵襲な手技を好む患者による最小侵襲胸腔ドレナージ手技へのシフトなどの動向は、世界の胸腔ドレナージ機器市場を独占すると予測されます。

世界の胸腔ドレナージ機器市場は近年大きく成長しており、今後も上昇傾向が続くと予測されます。市場は変革期を迎えており、患者のリアルタイムモニタリング、遠隔データアクセス、患者管理の改善を可能にする接続機能を備えた胸腔ドレナージシステムのデジタル化など、いくつかの重要な動向の影響を受けています。

さらに、胸部疾患の有病率の上昇、胸腔ドレナージ装置の継続的な技術進歩による効率性と安全性の向上、術後ケアに胸腔ドレナージ装置を必要とする肺切除や移植などの胸部手術件数の増加が、胸腔ドレナージ装置市場規模を押し上げています。新技術の研究活動が活発化していることや、確立された製薬医療技術企業の存在も、北米地域の需要の要因の一つです。ATMOS MedizinTechnik GmbH &Co.K、Becton, Dickinson and Company、その他の企業が市場で活発に活動しています。

ダイナミクス

胸部手術件数の増加が胸腔ドレナージデバイス市場の成長を牽引

胸部手術件数の増加は、胸腔ドレナージ装置市場を牽引する重要な要因です。胸腔ドレナージ装置は、心膜腔や胸膜腔から血液、体液、空気を排出することで、術後の問題を軽減し、胸水、タンポナーデ、気胸、出血などの懸念を最小限に抑えることができるため、胸部外科手術には欠かせないです。改良されたデジタル式ドレナージ装置が開発される以前は、古典的な3室吸引法が過去50年間胸部外科手術の標準でした。

例えば、2022年に発表された米国国立医学図書館の論文によると、米国だけでも約4,000人の心臓胸部外科医によって年間約53万例の一般胸部外科手術が行われており、その大半は男性（92％）で、平均年齢は56歳です。平均的な胸部外科医は年間135人の患者を手術しています。このような胸部外科手術の増加は、患者の治療と治療成績の向上における市場の成長の可能性を強調しています。

技術の進歩が胸腔ドレナージデバイス市場の成長を促進する

高度な設計を包含する胸腔ドレナージデバイスの進歩の拡大は、市場を牽引すると予想されます。例えば、2023年9月、Merit Medical Systems, Inc.は、Aspira Evacuated Drainage Bottleの発売を発表しました。Aspiraドレナージシステムは、再発性・症候性の胸水（肺の外側に溜まる体液）や悪性腹水（がんによって腹部に溜まる体液）の治療に使用されます。

さらに、アスピラドレナージシステムの適応である再発性胸水および悪性腹水のドレナージは、いずれも院内でのドレナージが必要となることが多く、患者ケアとQOLの向上に最先端のドレナージ技術が重要な役割を果たすことを示しています。したがって、より多くのヘルスケア機関や専門家が最先端のソリューションを採用するにつれて、胸腔ドレナージ装置市場は、予測期間中、効率、精度、患者の転帰を改善する技術的改良に後押しされて成長すると予想されます。

熟練した専門家の不足が市場の成長を妨げる

熟練した専門家の不足がこの市場の大きな抑制要因です。胸腔ドレナージは学際的な連携を必要とする高度な外科手術であり、看護師は胸腔チューブの挿入とケアにおいて重要な役割を果たします。しかし、研修医が挿入する胸腔チューブには問題が多く、さらなるトレーニングの必要性が強調されています。

さらに、胸腔チューブ挿入は放射線科医、肺専門医、胸部外科医が行う一般的な手技です。北米放射線学会（Radiological Society of North America）2022年の記事によると、欧州では人口10万人あたり13人の放射線科医がいるが、英国では10万人あたり8.5人しかいないため、英国では放射線科医が不足しています。このため、予測期間中に市場は成長すると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 胸部外科手術の増加
      • 技術の進歩
    • 抑制要因
      • 熟練した専門家の不足
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 製品別

  • 胸腔ドレナージシステム
    • ウォーターシールチェストドレナージシステム
    • ドライシールチェストドレナージシステム
    • デジタル式胸腔ドレナージシステム
  • 胸腔ドレナージキット
  • 胸腔ドレナージカテーテル
    • 胸腔穿刺カテーテル
    • 胸腔穿刺カテーテル
    • その他
  • トロカールドレーン
  • その他

第8章 材料タイプ別

  • シリコーン
  • ポリウレタン
  • ラテックス
  • その他

第9章 用途別

  • 心臓外科
  • 腫瘍学・疼痛管理
  • 胸部外科・呼吸器内科
  • 一般集中治療救急医療
  • その他

第10章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 心臓専門クリニック
  • 心臓外科センター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • ATMOS MedizinTechnik GmbH & Co. K
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Becton, Dickinson and Company
  • Cardinal Health.
  • Cook Group Incorporated
  • Getinge AB
  • Sinapi Biomedical
  • Teleflex Incorporated
  • Utah Medical Products, Inc.
  • Vygon SA
  • Sterimed Group

第14章 付録

目次
Product Code: MD7209

Overview

The trend such as the shift towards minimal invasive thoracic drainage procedures driven by patient preference for less invasive techniques is expected to dominate the global thoracic drainage devices market.

The global thoracic drainage devices market has grown significantly in recent years and is projected to continue on its upward trend. The market is undergoing a transformational period, influenced by several significant trends such as digitalization in chest drainage systems equipped with connectivity features allowing real-time monitoring of patients, remote data access, and improved patient management.

Furthermore, the rising prevalence of thoracic diseases, Continuous technological advancements in thoracic drainage devices have improved their efficiency and safety and increasing number of thoracic surgeries, including lung resections and transplantations, that requires thoracic drainage devices for post-operative care are driving up the thoracic drainage devices market size. The growing research activities for new technologies and presence of establish pharmaceutical medtech companies are some of the factors in demand from North American regions. With significant competitors like ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, and others actively operating in the market.

Dynamics

The Increasing Number of Thoracic Surgeries to Drive the Growth of the Thoracic Drainage Devices Market

The increasing number of thoracic surgeries is an important factor driving in the market for thoracic drainage devices. These devices are essential in cardiothoracic surgery because they allow for the drainage of blood, fluids, and air from the pericardial and pleural cavities, reducing post-operative problems and minimizing concerns such as effusions, tamponade, pneumothoraces, and hemorrhage. Prior to the development of improved digital drainage devices, the classic 3-chamber suction technique was the standard in thoracic surgery for the past five decades.

For instance, according to a National Library of Medicine article published in 2022, states that about 530,000 general thoracic surgery cases are performed annually in the U.S alone by approximately 4,000 cardiothoracic surgeons, the majority of them are male (92%), with an average age of 56 years. The average thoracic surgeon performs 135 patients per year. This increase in thoracic procedures emphasizes the market's potential for growth in enhancing patient care and outcomes.

The Advancements in Technologies will Drive the Thoracic Drainage Devices Market Growth

The growing advancements in thoracic drainage devices emcompassing advanced design is expected to drive the market. For instance, in September 2023, Merit Medical Systems, Inc. announced the launch of its Aspira Evacuated Drainage Bottle. The Aspira Drainage System is used to treat recurring and symptomatic pleural effusions (fluid buildup outside the lungs) and malignant ascites (fluid buildup in the abdomen caused by cancer).

Furthermore, the indications for the Aspira Drainage System for draining recurrent pleural effusions and malignant ascites, both of which frequently require in-hospital drainage, show the crucial role of cutting-edge drainage technologies in improving patient care and quality of life. Thus, as more healthcare organizations and professionals adopt cutting-edge solutions, the market for thoracic drainage devices is expected to grow, fueled by technological improvements that improve efficiency, precision, and patient outcomes over the forecast period.

The Lack of Availability of Skilled Professional Will Hamper the Growth of the Market

The lack of availability of skilled professional is the major restraint for this market. Thoracic drainage is an advanced surgical procedure that requires interdisciplinary collaboration, and nurses play a significant role in chest tube insertion and care. However, chest tubes inserted by resident physicians are frequently associated with problems, emphasizing the need for further training.

Furthermore, chest tube insertion is a common procedure performed by radiologists, pulmonary specialists, and thoracic surgeons. According to the Radiological Society of North America 2022 article, there is a shortage of radiologists in the U.K, since Europe has 13 radiologists per 100,000 people, but the rate in the U.K. is only 8.5 per 100,000. Thus, owing to this factor the market is expected to grow over the forecast period.

Segment Analysis

The global thoracic drainage devices market is segmented based on product, material type, application, end user and region.

Owing to the Better Effectiveness and Variety, the Chest Drainage Systems Segment Accounted for Approximately 47.2% of the Thoracic Drainage Devices Market Share

The chest drainage systems segment is expected to dominate the thoracic drainage device market. These systems are widely used in a variety of clinical settings, including cardiac surgery, cardiothoracic surgery, pulmonology, and critical care, to treat diseases such as pleural effusion, pneumothorax, hemothorax, and post-operative drainage.

This segment's is dominated due to the variety and effectiveness of chest drainage devices in removing air and fluids from the pleural area, hence aiding lung re-expansion and reducing problems. Furthermore, contemporary technological advancements in digital chest drainage systems, which allow for real-time monitoring and enhanced patient management, contribute to their widespread acceptability.

For instance, in July 2022, Centese, Inc. announced the first peer-reviewed study for its Thoraguard digital drainage system for cardiac surgery at Stanford University Medical Center, which was published in the Journal of Thoracic and Cardiovascular Surgery Open. Thoraguard is the first and only digital chest tube management system that delivers automated clog removal without human intervention while continuously and precisely monitoring vital physiological indicators to support clinical decision-making and enhance outcomes. Furthermore, when utilized during heart surgery, Thoraguard was demonstrated to be safe and efficacious when compared to standard analog chest tubes. Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Penetration

North America Accounted for Approximately 38.2% of the Market Share in 2022, Owing to the Increasing Number of Clinical Trials

The increasing number of clinical trials in North America is expected to dominate the thoracic drainage device market. Clinical trials play a vital role in determining the safety and efficacy of novel devices. For instance, the University of Oklahoma is conducting a clinical trial comparing the Digital Chest Tube Drainage System (Thopaz + ) to the Analog in Pediatric Patients." The purpose of the research is to assess the efficacy of digital (Thopaz + ) and analog (Pleur-evac) drainage devices in pediatric patients. The trial is an interventional, randomized, and controlled study that is expected to enroll 140 people.

Furthermore, the study is expected to be finished by April 1, 2024 and there have been no prospective randomized controlled trials comparing digital versus analog chest tube drainage systems in pediatric patients so far. This will be the first prospective randomized trial to look into the possible benefits of adopting a digital chest tube drainage system in pediatric patients.

Moreover, the increasing prevalence of chronic diseases in North America is also expected to drive the market. Chronic diseases such as heart disease and pulmonology disease are significant drivers of demand for thoracic drainage devices. As the population ages and lifestyle factors increase the prevalence of chronic diseases, the need for appropriate thoracic drainage treatments grows. Thus, owing to the above factors the region is expected to dominate over the forecast period.

Competitive Landscape

The major global players in the thoracic drainage devices market include: ATMOS MedizinTechnik GmbH & Co. K, Becton, Dickinson and Company, Cardinal Health., Cook Group Incorporated, Getinge AB, Sinapi Biomedical, Teleflex Incorporated, Utah Medical Products, Inc., Vygon SA, Sterimed Group, and among others.

COVID-19 Impact Analysis

The World Health Organization (WHO) reported more roughly 585.0 million confirmed COVID-19 cases as of August 2022, with around 6.4 million recorded deaths. However, research has shown that thoracic drainage systems play an important role in preventing the widespread development of COVID-19. Individuals with COVID-19 are at a higher risk of having acute respiratory distress syndrome (ARDS), which requires invasive mechanical ventilation.

Furthermore, COVID-19-related barotrauma frequently results in pneumothorax, necessitating chest tube insertion (thoracostomy). Furthermore, members of the German Health Alliance (GHA), which include prominent companies such as B. Braun, ATMOS MedizinTechnik GmbH & Co. KG, Getinge, and Drager, have seen a significant increase in global demand for their products, particularly thoracic drainage systems, since the beginning of 2020. ATMOS MedizinTechnik GmbH & Co. KG, for example, an innovative medical device maker, has increased production to meet increased demand, realizing that product categories such as drainage systems play a critical role in saving lives in the face of the COVID-19 epidemic.

Key Developments

  • On April 18, 2022, Merit Medical Systems, Inc., a global leader in the manufacture and marketing of healthcare technologies, stated the launch of the ReSolve Thoracostomy Tray. The new tray includes everything needed to execute a thoracostomy, a minimally invasive method that allows patients to avoid open surgery to drain fluids or air from the chest.
  • On December 15, 2020, Medela LLC stated that their Thopaz + Digital Chest Drainage and Monitoring System completed various quantitative tests demonstrating that its filtration system efficiently inhibits the passage of aerosolized viral particles such as SARS-CoV-2, the virus responsible for COVID-19.

Why Purchase the Report?

  • To visualize the global thoracic drainage devices market segmentation based on product, material type, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of thoracic drainage devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global thoracic drainage devices market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Number of Thoracic Surgeries
      • 4.1.1.2. The Advancements in Technologies
    • 4.1.2. Restraints
      • 4.1.2.1. The Lack of Availability of Skilled Professional
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Chest Drainage Systems*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      • 7.2.2.1. Water Seal Chest Drainage Systems
      • 7.2.2.2. Dry Seal Chest Drainage Systems
      • 7.2.2.3. Digital Chest Drainage Systems
  • 7.3. Thoracic Drainage Kits
  • 7.4. Pleural Drainage Catheters
    • 7.4.1. Thoracentesis Catheters
    • 7.4.2. Paracentesis Catheters
    • 7.4.3. Others
  • 7.5. Trocar Drains
  • 7.6. Others

8. By Material Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 8.1.2. Market Attractiveness Index, By Material Type
  • 8.2. Silicone*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Polyurethane
  • 8.4. Latex
  • 8.5. Other

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Cardiac Surgery*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Oncology & Pain Management
  • 9.4. Thoracic Surgery & Pulmonology
  • 9.5. General Intensive Care Emergency Medicine
  • 9.6. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgery Centers
  • 10.4. Cardiac Specialty Clinics
  • 10.5. Cardiothoracic Centers
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. ATMOS MedizinTechnik GmbH & Co. K*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Becton, Dickinson and Company
  • 13.3. Cardinal Health.
  • 13.4. Cook Group Incorporated
  • 13.5. Getinge AB
  • 13.6. Sinapi Biomedical
  • 13.7. Teleflex Incorporated
  • 13.8. Utah Medical Products, Inc.
  • 13.9. Vygon SA
  • 13.10. Sterimed Group

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us